°Ç¸ç³Ô¹Ï

Skip to main content

Research and statistics

Skip to results
536 results that are All research and statistics, sorted by Updated (newest)
From UK Health Security Agency (UKHSA)
  • The latest information on mpox clade Ib and clade IIb cases in the UK. Previous reports from June 2022 to January 2025 include information on clade IIb only.

  • Official statistics data and reporting on vaccine uptake for the RSV (respiratory syncytial virus) vaccination programme for pregnant women.

  • Vaccine uptake data for the respiratory syncytial virus (RSV) vaccination programme for older adults.

  • MRSA, MSSA, Gram-negative bacteraemia infections by organisation and location of onset, and Clostridioides difficile infections (CDI) by organisation and prior trust exposure.

  • Cumulative weekly data on invasive pneumococcal disease (IPD) infections due to serotypes not in Prevenar 13â„¢ vaccine.

  • Cumulative weekly data on invasive pneumococcal disease (IPD) infections due to serotypes in Prevenar 13â„¢ in England.

  • Quarterly reports, with commentary, on cases confirmed by UK Health Security Agency's Virus Reference Department or local laboratory testing.

  • The latest quarterly reports of provisional data for tuberculosis (TB) notifications in England.

  • Resources and information relating to the UKHSA's investigation of meningococcal bacteria carriage amongst students aged 18 to 24 in Kent taking place from May 2026.

  • Reports presenting data since 2020 for sexually transmitted infections (STIs) in the East Midlands.

  • Reports presenting data for sexually transmitted infections (STIs) in the West Midlands.

  • Rapid evidence summary identifying evidence on the effectiveness of interventions to reduce gonorrhoea in heterosexual adolescents and young adults, aged 15 to 25 years, from peer-reviewed literature.

  • HIV surveillance data in the UK by demographic characteristics and geographical region.

  • Tables showing confirmed toxigenic C. diphtheriae cases among asylum seekers in England between 2022 and 2026.

  • Qualitative assessment of the risk that Zika virus presents to the UK population.

  • Trends in meticillin resistant (MRSA) and meticillin susceptible (MSSA) Staphylococcus aureus, Gram-negative bacteraemia and Clostridioides difficile infection.

  • Annual data of reported Giardia infections in England and Wales since 2007.

  • Statistical release in response to cases of invasive meningococcal disease in the UK.

  • Vaccine uptake data and commentary about the pertussis (whooping cough) vaccination programme for pregnant women.

  • Latest UK Health Security Agency hepatitis C virus reports and supporting documents, for England and the UK.